(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACCESS OSMOLEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ACCESS OSMOLEX

ST13

US500000088059617

Class

42

Filing

88059617

Registration

6086286

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

47

Latest update

06/24/2025

Trademark type

Combined

Nice classes

42

Filing date

07/31/2018

Registration date

06/23/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/23/2020

Last transaction

06/24/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/21/2018

First use in commerce

12/21/2018

Drawing code

3

Owner type

16

Owner location

Rockville, MD

Examiner

LE, MARGARET

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ACCESS" within a circle, the circle to the left of the word "OSMOLEX".

Holders and representatives

Holders

ADAMAS PHARMA, LLC
ADAMAS PHARMACEUTICALS, INC.
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság

Representatives

Mark D. Simpson Saul Ewing LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Providing computerized solution-based technologies for the purpose of patient support services to assist patients in accessing medicine; online non-downloadable software for accessing an online searchable database in the field of medical researchdrug delivery technologyimmediate release and controlled release drugsdrug interactions; online non-downloadable software in which users can create a profile and input drugs to review drug interactions

Publications

History of USPTO decisions and trademark events.

47 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/23/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/18/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/18/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/18/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/18/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/18/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/01/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/01/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/01/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/01/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/01/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/13/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/10/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/23/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/16/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/15/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/15/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/15/2020

IUAF

USE AMENDMENT FILED

04/30/2020

EISU

TEAS STATEMENT OF USE RECEIVED

04/30/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/01/2019

EX1G

SOU EXTENSION 1 GRANTED

10/30/2019

EXT1

SOU EXTENSION 1 FILED

10/30/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/30/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/30/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/05/2019

PUBO

PUBLISHED FOR OPPOSITION

03/05/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/13/2019

ALIE

ASSIGNED TO LIE

01/30/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/15/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

01/15/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/15/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

01/15/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/14/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/14/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/14/2019

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

12/21/2018

GPRA

PRIORITY ACTION E-MAILED

12/21/2018

CPRA

PRIORITY ACTION WRITTEN

12/21/2018

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

12/18/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

12/11/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/23/2018

DOCK

ASSIGNED TO EXAMINER

11/16/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/07/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/06/2018

NWAP

NEW APPLICATION ENTERED

08/03/2018

Continuous trademark protection

Get notified about every new filing that threatens ACCESS OSMOLEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.